在“2018深圳心力衰竭国际发展论坛暨心力衰竭治疗研讨会·深圳站”会议上，来自延世大学元州医学院的Yoo Byung Su教授为我们带来了'How hospitalization can be used for the optimization of heart failure drug and device therapy（如何利用住院治疗优化心力衰竭药物和设备治疗）'的精彩报告。
Outlines
Background
Key component of optimized HF management during hospitalization
Device implantation
Summary
Population aged 65 and older
Projected prevalence of HF in USA and Korea
Increasing Prevalence, Hospital Admission and Cost
The majority of healthcare costs for HF patients in Korea was related to hospitalization
Heart Failure (HF) is a Disease of High Mortality – Korean HF Registry Data
Predictors of In-hospital Mortality
Validation of the MAGGIC HF risk score for predicting mortality : similar result
Post-discharge, the prognosis is poor
Mortality is particularly high in the early phase after hospitalization
Rehospitalization is particularly high in the early phase after hospitalization:
The burden of HF each hospitalization = start of a new vulnerable phase
Hospitalization is the key moment to optimize treatment
Hospitalization is the key moment to optimize treatment
Optimize heart failure care--from hospital discharge to patient follow-up
